<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02717260</url>
  </required_header>
  <id_info>
    <org_study_id>2015-A01554-45</org_study_id>
    <nct_id>NCT02717260</nct_id>
  </id_info>
  <brief_title>Inhibition Transcranial Random Noise Stimulation</brief_title>
  <acronym>inhibistim</acronym>
  <official_title>Inhibition Control Modulation by Transcranial Random Noise Stimulation (tRNS ) on the Prefrontal Cortex Measured by Change in Go no Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital le Vinatier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hôpital le Vinatier</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Inhibition control deficits is a major risk factor in the transition to the act in suicidal&#xD;
      patients. Neuroimaging studies have shown that this failure was associated with hypoactivity&#xD;
      in the prefrontal cortex (PFC), a brain area involved in the control of impulsivity. It was&#xD;
      recently shown that a noninvasive brain stimulation session applied on the PFC reduces&#xD;
      transiently impulsivity in healthy volunteers. Noninvasive brain stimulation modulates the&#xD;
      activity and connectivity of neural network connected to the stimulation site. The&#xD;
      investigators assume that a repetition of noninvasive brain stimulation sessions on the PFC&#xD;
      will allow a more intense and longer lasting effect on impulsivity and cognitive control in&#xD;
      healthy volunteers compared to a single session and to placebo stimulation. The investigators&#xD;
      assume that this behavioral change will be accompanied by a change in brain activity measured&#xD;
      by resting EEG for the patients in the active group. A more intense and longer lasting effect&#xD;
      is an essential step to transfer these results to patient populations.&#xD;
&#xD;
      The main objective is to study the effect of bilateral stimulation of the PFC by transcranial&#xD;
      random noise stimulation (tRNS) on the inhibition control measured by the cognitive motor&#xD;
      inhibition capacity (Go NoGo test). The secondary objectives are to study the effect of tRNS&#xD;
      on verbal inhibition (measured with the Hayling test); on anxiety (measured with the&#xD;
      State-trait anxiety inventory (STAI)),on angry (measured with the State-trait anger&#xD;
      expression inventory (STAXI)) on verbal and nonverbal inhibition (measured by the Stroop&#xD;
      test), on impulsive behavior (measured by the Barrat impulsiveness scale (BIS 10)) and on the&#xD;
      neuronal electrical activity measured by EEG.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects are stimulated 3 times in a day. Each 20 minutes stimulation are separated by a&#xD;
      period of at least 30 minutes. Before and after each stimulation, inhibition is evaluated by&#xD;
      cognitive tests (Go Nogo test, Stroop test, Hayling test) and by the BIS 10 scale. During the&#xD;
      stimulation, subjects compleat the STAXI and STAI scales. Cognitive tests are repeated 24&#xD;
      hours and 8 days after the stimulation to evaluate duration of the effect. Possible side&#xD;
      effects will be notified throughout the protocol.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2, 2016</start_date>
  <completion_date type="Actual">September 29, 2016</completion_date>
  <primary_completion_date type="Actual">September 29, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in go no go test</measure>
    <time_frame>15 minutes after the stimulation</time_frame>
    <description>errors and reaction times</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Stroop test</measure>
    <time_frame>15 minutes after the stimulation</time_frame>
    <description>errors and reaction times</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Hayling test</measure>
    <time_frame>15 minutes after the stimulation</time_frame>
    <description>errors and reaction times</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in BIS 10</measure>
    <time_frame>24 hours and 8 days after stimulations</time_frame>
    <description>motor impulsivity, cognitive impulsivity, non planning impulsivity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in STAXI</measure>
    <time_frame>24 hours and 8 days after stimulations</time_frame>
    <description>score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in STAI</measure>
    <time_frame>24 hours and 8 days after stimulations</time_frame>
    <description>score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in EEG</measure>
    <time_frame>24 hours and 8 days after stimulations</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>occurrence of adverse effects</measure>
    <time_frame>8 days after stimulations</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Impulsive Behavior</condition>
  <condition>Inhibition</condition>
  <arm_group>
    <arm_group_label>Sham transcranial noise stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>subjects are stimulated 3 times with sham transcranial random noise stimulation (tRNS) (Starstim) with a 30 seconds offset</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1 Active transcranial random noise stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subjects are stimulated 1 time with active transcranial random noise stimulation (tRNS) (Starstim) at 2mA with a oscillatory frequency between 100 and 500 Hz during 20 minutes and 2 times with sham tRNS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3 Active transcranial random noise stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subjects are stimulated 3 times with active transcranial random noise stimulation (tRNS) (Starstim) at 2mA with a oscillatory frequency between 100 and 500 Hz during 20 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial random noise stimulation (tRNS) (Starstim)</intervention_name>
    <description>subjects are stimulated 3 times in a day by transcranial random noise stimulation (tRNS) (Starstim). each 20 minutes stimulation are separated by a period of at least 30 minutes. before and after each stimulation, inhibition is evaluated by cognitive tests: go nogo test, stroop test, Hayling test and by the BIS 10 scale. During the stimulation, subjects compleat the STAXI and STAI scales. Cognitive tests are repeated 24 hours and 8 days after the stimulation to evaluate duration of the effect. Possible side effects will be notified throughout the protocol.</description>
    <arm_group_label>1 Active transcranial random noise stimulation</arm_group_label>
    <arm_group_label>3 Active transcranial random noise stimulation</arm_group_label>
    <arm_group_label>Sham transcranial noise stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age between 18 and 45 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  inability to give consent&#xD;
&#xD;
          -  Under 18 years&#xD;
&#xD;
          -  over 45 years&#xD;
&#xD;
          -  pregnant women&#xD;
&#xD;
          -  nursing mothers&#xD;
&#xD;
          -  History of neurological or psychiatric disorders and personality disorders in Cluster&#xD;
             impulsivity (cluster B) according to Diagnostic and Statistical Manual (DSM) IV&#xD;
&#xD;
          -  french National Adult Reading Test (fNART): score below the 5th percentile&#xD;
&#xD;
          -  Contraindications to the practice of transcranial brain stimulation as international&#xD;
             safety recommendations (Rossi et al., 2009)&#xD;
&#xD;
          -  Processing or recent psychotropic&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>HAESEBAERT Frederic, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HOPITAL VINATIER</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ch Le Vinatier</name>
      <address>
        <city>Lyon</city>
        <state>Rhone Alpes</state>
        <zip>69678</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <study_first_submitted>January 28, 2016</study_first_submitted>
  <study_first_submitted_qc>March 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2016</study_first_posted>
  <last_update_submitted>May 9, 2017</last_update_submitted>
  <last_update_submitted_qc>May 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hôpital le Vinatier</investigator_affiliation>
    <investigator_full_name>HAESEBAERT</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Impulsive Behavior</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

